Changes in Brighter’s board
Board members Tove Andersson, Jan Stålemark and Emanuel Lipschütz resign from the board with immediate effect due to disagreement about how the company should be operated and focus going forward. Due to this, the company will convene an extraordinary shareholders meeting shortly to appoint an interim board.
The members' decision is not linked to the previously announced preliminary investigation into the released Chairman of the Board. Truls Sjöstedt will remain as Chairman until the extraordinary shareholders meeting for practical matters concerning the board, but in connection to this he leaves the board seat at the disposal of the meeting.
“The company's operational work continues according to plan, but there will be no new board decisions until after the extraordinary general meeting,” says Henrik Norström, CEO of Brighter.
For further information, please contact:
Henrik Norström, CEO
+46 733 40 30 45
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, firstname.lastname@example.org, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 20:23 CET on July 13, 2020.